Mapp Biopharmaceutical (United States)
San Diego, USA · 2 authors
Mapp Biopharmaceutical (United States) (San Diego, USA): 2 authors and 12 papers in the de novo peptide sequencing catalog.
Papers (12)
- Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases (2025, Cell Systems)
- Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases (2024, bioRxiv)
- De novo sequencing and construction of a unique antibody for the recognition of alternative conformations of cytochrome c in cells (2022, Proceedings of the National Academy of Sciences)
- Antibody de novo Sequencing (2017, Analytical Characterization of Biotherapeutics)
- A multi-protease, multi-dissociation, bottom-up-to-top-down proteomic view of the Loxosceles intermedia venom (2017, Scientific Data)
- De Novo MS/MS Sequencing of Native Human Antibodies (2017, Journal of Proteome Research)
- Neutron-encoded Signatures Enable Product Ion Annotation From Tandem Mass Spectra (2013, Molecular & Cellular Proteomics)
- Sequencing-Grade De novo Analysis of MS/MS Triplets (CID/HCD/ETD) From Overlapping Peptides (2013, Journal of Proteome Research)
- Shotgun Protein Sequencing with Meta-contig Assembly (2012, Molecular & Cellular Proteomics)
- The spectral networks paradigm in high throughput mass spectrometry (2012, Molecular BioSystems)
- Resurrection of a clinical antibody: Template proteogenomic de novo proteomic sequencing and reverse engineering of an anti‐lymphotoxin‐α antibody (2011, PROTEOMICS)
- Template Proteogenomics: Sequencing Whole Proteins Using an Imperfect Database (2010, Molecular & Cellular Proteomics)